These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9469843)

  • 1. In vitro gene transfer using human papillomavirus-like particles.
    Touze A; Coursaget P
    Nucleic Acids Res; 1998 Mar; 26(5):1317-23. PubMed ID: 9469843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comparative Study on Delivery of Externally Attached DNA by Papillomavirus VLPs and Pseudoviruses.
    Brendle S; Cladel N; Balogh K; Alam S; Christensen N; Meyers C; Hu J
    Vaccines (Basel); 2021 Dec; 9(12):. PubMed ID: 34960247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Assembly of Virus-Like Particles and Their Applications.
    Le DT; Müller KM
    Life (Basel); 2021 Apr; 11(4):. PubMed ID: 33920215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs.
    Zepeda-Cervantes J; Ramírez-Jarquín JO; Vaca L
    Front Immunol; 2020; 11():1100. PubMed ID: 32582186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-based vehicles for biomimetic RNAi delivery.
    Pottash AE; Kuffner C; Noonan-Shueh M; Jay SM
    J Biol Eng; 2019; 13():19. PubMed ID: 30891095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver-specific Gene Delivery Using Engineered Virus-Like Particles of Hepatitis E Virus.
    Lee EB; Kim JH; Hur W; Choi JE; Kim SM; Park DJ; Kang BY; Lee GW; Yoon SK
    Sci Rep; 2019 Feb; 9(1):1616. PubMed ID: 30733562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient Production of Papillomavirus Gene Delivery Vectors in Defined In Vitro Reactions.
    Cerqueira C; Thompson CD; Day PM; Pang YS; Lowy DR; Schiller JT
    Mol Ther Methods Clin Dev; 2017 Jun; 5():165-179. PubMed ID: 28497074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cruising the cellular highways: How human papillomavirus travels from the surface to the nucleus.
    DiGiuseppe S; Bienkowska-Haba M; Guion LG; Sapp M
    Virus Res; 2017 Mar; 231():1-9. PubMed ID: 27984059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of Human papillomavirus pseudovirions in plants and their use in pseudovirion-based neutralisation assays in mammalian cells.
    Lamprecht RL; Kennedy P; Huddy SM; Bethke S; Hendrikse M; Hitzeroth II; Rybicki EP
    Sci Rep; 2016 Feb; 6():20431. PubMed ID: 26853456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Cell-Free Assembly System for Generating Infectious Human Papillomavirus 16 Capsids Implicates a Size Discrimination Mechanism for Preferential Viral Genome Packaging.
    Cerqueira C; Pang YY; Day PM; Thompson CD; Buck CB; Lowy DR; Schiller JT
    J Virol; 2016 Jan; 90(2):1096-107. PubMed ID: 26559838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different applications of virus-like particles in biology and medicine: Vaccination and delivery systems.
    Shirbaghaee Z; Bolhassani A
    Biopolymers; 2016 Mar; 105(3):113-32. PubMed ID: 26509554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis E Virus Produced from Cell Culture Has a Lipid Envelope.
    Qi Y; Zhang F; Zhang L; Harrison TJ; Huang W; Zhao C; Kong W; Jiang C; Wang Y
    PLoS One; 2015; 10(7):e0132503. PubMed ID: 26161670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of two different assay kits for the detection of secreted alkaline phosphatase in HPV antibody neutralization assays.
    Kemp TJ; Matsui K; Shelton G; Safaeian M; Pinto LA
    Hum Vaccin Immunother; 2015; 11(2):337-46. PubMed ID: 25695397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus type 16 pseudovirions with few point mutations in L1 major capsid protein FG loop could escape actual or future vaccination for potential use in gene therapy.
    Fleury MJ; Touzé A; Coursaget P
    Mol Biotechnol; 2014 May; 56(5):479-86. PubMed ID: 24639327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA vaccines delivered by human papillomavirus pseudovirions as a promising approach for generating antigen-specific CD8+ T cell immunity.
    Peng S; Ma B; Chen SH; Hung CF; Wu T
    Cell Biosci; 2011 Jul; 1():26. PubMed ID: 21798027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV pseudovirions as DNA delivery vehicles.
    Ma B; Roden RB; Hung CF; Wu TC
    Ther Deliv; 2011 Apr; 2(4):427-30. PubMed ID: 21709779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral nanoparticles as macromolecular devices for new therapeutic and pharmaceutical approaches.
    Grasso S; Santi L
    Int J Physiol Pathophysiol Pharmacol; 2010 Jul; 2(2):161-178. PubMed ID: 21383892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational HIV-1 envelope on particulate structures: a tool for chemokine coreceptor binding studies.
    Tagliamonte M; Tornesello ML; Buonaguro FM; Buonaguro L
    J Transl Med; 2011 Jan; 9 Suppl 1(Suppl 1):S1. PubMed ID: 21284899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of different vaccine delivery systems for cancer therapy.
    Bolhassani A; Safaiyan S; Rafati S
    Mol Cancer; 2011 Jan; 10():3. PubMed ID: 21211062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccination.
    Graham BS; Kines RC; Corbett KS; Nicewonger J; Johnson TR; Chen M; LaVigne D; Roberts JN; Cuburu N; Schiller JT; Buck CB
    Mucosal Immunol; 2010 Sep; 3(5):475-86. PubMed ID: 20555315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.